| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 08/03/2006 | WO2006061638A3 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 08/03/2006 | US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | CA2594951A1 Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same |
| 08/02/2006 | EP1686113A1 Inhibitors of aspartyl protease |
| 08/02/2006 | CN1267419C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | US20060167078 Substituted benzodioxepins |
| 07/26/2006 | EP1682552A1 Tocopherol-modified therapeutic drug compounds |
| 07/26/2006 | EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 07/26/2006 | EP1682537A1 Modulators of cellular adhesion |
| 07/26/2006 | EP1682528A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES |
| 07/26/2006 | EP0902003B1 Novel tetralone or benzopyranone derivatives and process for producing the same |
| 07/26/2006 | EP0655061B2 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric |
| 07/26/2006 | CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 07/26/2006 | CN1809552A Cannabinoid derivatives, methods of making, and use thereof |
| 07/26/2006 | CN1809539A Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
| 07/25/2006 | CA2161138C Oxidation products of cephalomannine |
| 07/20/2006 | US20060160884 N-{[4-(but-2-ynyloxy)phenyl]sulfonyl}-1-(2-fluorobenzyl)-5-methoxy-2-methyltryptophan; for treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ulcerative colitis, or Crohn's disease |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160773 Combretastatin derivatives with cytotoxic action |
| 07/19/2006 | EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/19/2006 | EP1680401A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 07/19/2006 | CN1264839C Non-nucleoside reverse transcriptase inhibitors |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078223 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture |
| 07/18/2006 | CA2341890C Oxygen-containing heterocyclic compounds |
| 07/18/2006 | CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 07/13/2006 | WO2006072430A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 07/13/2006 | US20060154943 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens |
| 07/13/2006 | CA2576332A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 07/12/2006 | EP1678130A2 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
| 07/12/2006 | EP1677785A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | CN1802366A C-glycoside derivatives and salts thereof |
| 07/11/2006 | US7074945 Metal alkoxide taxane derivatives |
| 07/11/2006 | US7074933 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
| 07/11/2006 | US7074819 Benzopyran or thiobenzopyran derivatives |
| 07/11/2006 | US7074789 Kinase inhibitors |
| 07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |
| 07/11/2006 | CA2244870C N,n-disubstituted amic acid derivatives |
| 07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 07/06/2006 | WO2006071958A1 Compounds useful as chemokine receptor antagonists |
| 07/06/2006 | WO2006070202A1 Pyrazole derivatives having kinase modulating activity |
| 07/06/2006 | WO2006070195A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/06/2006 | WO2006069776A1 5-ht7 receptor antagonists |
| 07/06/2006 | CA2593993A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/06/2006 | CA2590666A1 5-ht7 receptor antagonists |
| 07/06/2006 | CA2590586A1 Substituted biaryl analogues |
| 07/05/2006 | EP1676844A1 5-HT7 receptor antagonists |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 06/29/2006 | US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 06/29/2006 | US20060142377 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 06/29/2006 | US20060142339 gastrointestinal disorders hypermotility, irritable bowel syndrome, constipation or diarrhea |
| 06/29/2006 | US20060141589 Method of producing macrolide compound |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |
| 06/28/2006 | CN1261426C Iodobenzopyrran-4-one derivatives having fungicidal activity |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067233 a photoresist composition of a polyether; a diphenyl propenol polymerized with epichlorhydrin, an acrylate resin, a curing agent, and an organic solvent; a high curing efficiency, brightness; prevents the formation of remnant in photoresist patterns |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006063763A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/22/2006 | WO2006026430A3 Cyclopamine analogues and methods of use thereof |
| 06/22/2006 | US20060135791 Method of purifying dianhydrides |
| 06/22/2006 | US20060135596 Amorphous form of a drug |
| 06/22/2006 | CA2591413A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | CA2591033A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | CA2589363A1 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | CA2587934A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/15/2006 | WO2006062890A1 Method of making imidazole-2-thiones |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006015860A3 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/15/2006 | US20060127986 Genetically engineered Recombinant actinomycete cells for use as tool for the generation of heterologous proteins; contains nucleic acid molecules which comprise at least two modules that encode a modular polyketide synthase |
| 06/15/2006 | US20060124014 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 06/15/2006 | CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/15/2006 | CA2589274A1 Inhibitors of protein kinases |
| 06/15/2006 | CA2589271A1 Urea inhibitors of map kinases |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors |
| 06/14/2006 | EP1667988A1 Coumarins as inos inhibitors |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/08/2006 | WO2006003479A3 New pseudopolymorph of desloratadine formed with carbon dioxide |